FAST NEWS: Luye Pharma’s Schizophrenia Drug Wins FDA Approval
The latest: Drug maker Luye Pharma Group Ltd. announced Sunday that its drug Rykindo has been approved by the U.S. Food and Drug Administration (FDA) as a treatment for schizophrenia…
Recent Articles
RELATED ARTICLES
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Ascentage Pharma soars on deal with cancer drug competitor
6855.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
Discover hidden China stock gems in our weekly newsletter